By now you have likely heard of hemp-derived CBD, the major non-psychoactive cannabinoid in cannabis. Hemp-derived CBD is not the same as marijuana and is sourced from industrial hemp plants which are grown for their seeds and fiber. Because of its powerful antioxidant and anti-inflammatory benefits, CBD Paste UK has been researched for its therapeutic potential, and currently there is published research that supports its benefits in the treatment of epilepsy, inflammation, anxiety disorders, diabetes and a number of other common physical and neuropsychiatric conditions. CBD has been studied for its promising anticancer properties. What you may not have heard of is a relatively new commercially available hemp-based product that is 1000 times stronger than CBD. Meet the cannabis superhero, CBDa.
What is cannabidiolic acid (CBDa)?
CBDa is one of an estimated 113 compounds called cannabinoids found in the cannabis plant. Cannabinoids can affect the endocan CBDa is actually a precursor of CBD prior to a process called decarboxylation which removes the acid through a heating process.
Most scientific research has been focused on the pharmacological traits of the two famous cannabinoids – the psychoactive compound found in marijuana called delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), the non-psychoactive compound. Not until 2008 did scientists discover that the more raw form of CBDa held some very remarkable therapeutic benefits. They discovered that CDBa had a similar structure to common non-steroidal anti-inflammatory pain medications like acetaminophen and ibuprofen. CBDa inhibits COX-2, the same chemical found in the body that is inhibited by these common painkillers.
Research studies have noted that “agents that would inhibit while sparing represent an attractive therapeutic development and could represent a major advance in the treatment of rheumatoid arthritis and osteoarthritis, as well as a diverse array of other conditions” which has sparked great interest in CBDa for treatment of these conditions. CDBa is a very promising plant-based medicine for inflammation and pain, but researchers are finding that there are more therapeutic benefits than previously known.